Beam Therapeutics

Beam Therapeutics is a biotechnology company specializing in precision genetic medicine. They focus on developing therapies using base editing technology to precisely edit single nucleotides in DNA, aiming to treat a variety of genetic diseases. Founded in 2017 by leading scientists in the field, Beam Therapeutics has rapidly advanced its pipeline and secured significant funding through partnerships and public offerings. Their innovative approach holds promise for creating more effective and safer treatments compared to traditional gene-editing methods.

Recent Posts by Beam Therapeutics

1-13 of 13